Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study.
about
The association between Diabetes mellitus and DepressionTherapeutic Use of Metformin in Prediabetes and Diabetes PreventionNIDDK international conference report on diabetes and depression: current understanding and future directionsDepressive symptoms, antidepressant use, and the incidence of diabetes in the Black Women's Health Study.Prevention of Diabetes Through the Lifestyle Intervention: Lessons Learned from the Diabetes Prevention Program and Outcomes Study and its Translation to PracticeUse of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults.Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review.Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association?Antidepressant drug use and future diabetes risk.Depressive symptoms, psychiatric medication use, and risk of type 2 diabetes: results from the Health and Retirement StudyTaking the Perspective that a Depressive State Reflects Inflammation: Implications for the Use of AntidepressantsDepression as a predictor of weight regain among successful weight losers in the diabetes prevention program.Antidepressant use, depression, and new-onset diabetes among elderly Medicare beneficiaries.Is ignorance bliss? Depression, antidepressants, and the diagnosis of prediabetes and type 2 diabetes.Weight and metabolic effects of dietary weight loss and exercise interventions in postmenopausal antidepressant medication users and non-users: a randomized controlled trial.Comparative effectiveness in pain-related outcomes and health care utilizations between veterans with major depressive disorder treated with duloxetine and other antidepressants: a retrospective propensity score-matched comparison.The risk of new-onset diabetes in antidepressant users - A systematic review and meta-analysisUse of antidepressants and the risk of type 2 diabetes mellitus: a nested case-control study.Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program.Use of antidepressant agents and the risk of type 2 diabetes.Depression, metabolic control, and antidepressant medication in young patients with type 1 diabetes.Diabetes mellitus associated with clomipramine treatment: a retrospective analysis.Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder.Antidepressant use and glycemic control.The Impact of Antidepressant Therapy on Glycemic Control in Canadian Primary Care Patients With Diabetes Mellitus.Effect of collaborative depression treatment on risk for diabetes: A 9-year follow-up of the IMPACT randomized controlled trialCombination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study
P2860
Q26741886-E3658FB2-C7C8-460F-AD9C-70D01CC4ED55Q26822066-F3929F2C-04F4-4A49-AB45-264ED9187065Q33960231-245E4749-820B-4519-9F69-1E859DF88B6BQ33960278-ADF931A9-1111-40F1-8170-ECC0EDC190A2Q34459235-2D0E9CF6-DBA7-426A-A51F-1E4578A9F9D0Q34631395-1225740E-5CF5-4346-AD18-F4DBAB0AA4F2Q34996871-9F0835EB-1BA3-4D47-A373-E235C0BBD88AQ35417546-ED4099FB-D789-4ED9-AC47-EA46C6A944D8Q35456399-43ACCE5E-27FD-4895-B4B2-02E76FCB1D47Q35587402-F6DD9B92-42DA-45AF-8A55-D2B54E6822C9Q36021649-18CAEA13-2398-4766-A429-FEA04D44975BQ36171115-5B3CEFDD-C3F4-4A5E-B33C-E51EBF14F6F2Q36560357-8404E93F-4C7B-4BBA-974F-04A5449A5716Q36674976-0730685A-D74F-4363-8935-98ACFDD62146Q37049657-9A67A987-695E-4C54-AD8F-3E6DD9761B61Q37238741-448F1A13-C931-4BB8-8DA9-099188BCE1FDQ39456635-3E453567-4074-4BD3-94F1-0007B491886EQ41185364-D0565E4E-D9EF-46D0-B706-A3D66B06432DQ43858341-4FCC04EC-E8F8-4DC8-92A5-2DCCDB035317Q45069681-82C3B8C7-219D-47F1-BE7C-31264353EADDQ46133442-B66FD6C0-8F5B-4563-95ED-38E8A109059DQ46213141-047C5B65-061C-475A-94FB-719B8B59667BQ48453928-FE42D74D-F50A-49C8-BD34-5D7DDAF7C524Q48773640-CA4C1D1D-8DF7-4839-ADC8-2C6D0A6C92D8Q50726991-79F10682-0738-4019-B58A-EED2F77E6D6AQ55410230-C948B3AE-8A6B-4F02-9FAC-CDFD35C29AF4Q58715887-8314EA13-C3D9-400E-B9F0-A9C393D8C6B4Q58803192-FF4EF3D3-65FB-4D65-BF81-D8A2A79B02A0
P2860
Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Antidepressant medicine use an ...... ention program outcomes study.
@ast
Antidepressant medicine use an ...... ention program outcomes study.
@en
Antidepressant medicine use an ...... ention program outcomes study.
@nl
type
label
Antidepressant medicine use an ...... ention program outcomes study.
@ast
Antidepressant medicine use an ...... ention program outcomes study.
@en
Antidepressant medicine use an ...... ention program outcomes study.
@nl
prefLabel
Antidepressant medicine use an ...... ention program outcomes study.
@ast
Antidepressant medicine use an ...... ention program outcomes study.
@en
Antidepressant medicine use an ...... ention program outcomes study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Antidepressant medicine use an ...... ention program outcomes study.
@en
P2093
David G Marrero
David W Price
Mark Peyrot
Richard R Rubin
P2860
P304
P356
10.2337/DC10-1033
P407
P577
2010-08-30T00:00:00Z